Lower regional gray matter volume in the absence of higher cortical amyloid burden in late-life depression

Abstract Late-life depression (LLD) is associated with a risk of developing Alzheimer’s disease (AD). However, the role of AD-pathophysiology in LLD, and its association with clinical symptoms and cognitive function are elusive. In this study, one hundred subjects underwent amyloid positron emission...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Akihiro Takamiya, Thomas Vande Casteele, Michel Koole, François-Laurent De Winter, Filip Bouckaert, Jan Van den Stock, Stefan Sunaert, Patrick Dupont, Rik Vandenberghe, Koen Van Laere, Mathieu Vandenbulcke, Louise Emsell
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/6cf5814ddb3f4fdf95d048dcf2f41a10
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6cf5814ddb3f4fdf95d048dcf2f41a10
record_format dspace
spelling oai:doaj.org-article:6cf5814ddb3f4fdf95d048dcf2f41a102021-12-02T17:06:24ZLower regional gray matter volume in the absence of higher cortical amyloid burden in late-life depression10.1038/s41598-021-95206-02045-2322https://doaj.org/article/6cf5814ddb3f4fdf95d048dcf2f41a102021-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-95206-0https://doaj.org/toc/2045-2322Abstract Late-life depression (LLD) is associated with a risk of developing Alzheimer’s disease (AD). However, the role of AD-pathophysiology in LLD, and its association with clinical symptoms and cognitive function are elusive. In this study, one hundred subjects underwent amyloid positron emission tomography (PET) imaging with [18F]-flutemetamol and structural MRI: 48 severely depressed elderly subjects (age 74.1 ± 7.5 years, 33 female) and 52 age-/gender-matched healthy controls (72.4 ± 6.4 years, 37 female). The Geriatric Depression Scale (GDS) and Rey Auditory Verbal Learning Test (RAVLT) were used to assess the severity of depressive symptoms and episodic memory function respectively. Amyloid deposition was quantified using the standardized uptake value ratio. Whole-brain voxel-wise comparisons of amyloid deposition and gray matter volume (GMV) between LLD and controls were performed. Multivariate analysis of covariance was conducted to investigate the association of regional differences in amyloid deposition and GMV with clinical factors, including GDS and RAVLT. As a result, there were no significant group differences in amyloid deposition. In contrast, LLD showed significant lower GMV in the left temporal and parietal region. GMV reduction in the left temporal region was associated with episodic memory dysfunction, but not with depression severity. Regional GMV reduction was not associated with amyloid deposition. LLD is associated with lower GMV in regions that overlap with AD-pathophysiology, and which are associated with episodic memory function. The lack of corresponding associations with amyloid suggests that lower GMV driven by non-amyloid pathology may play a central role in the neurobiology of LLD presenting as a psychiatric disorder. Trial registration: European Union Drug Regulating Authorities Clinical Trials identifier: EudraCT 2009-018064-95.Akihiro TakamiyaThomas Vande CasteeleMichel KooleFrançois-Laurent De WinterFilip BouckaertJan Van den StockStefan SunaertPatrick DupontRik VandenbergheKoen Van LaereMathieu VandenbulckeLouise EmsellNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Akihiro Takamiya
Thomas Vande Casteele
Michel Koole
François-Laurent De Winter
Filip Bouckaert
Jan Van den Stock
Stefan Sunaert
Patrick Dupont
Rik Vandenberghe
Koen Van Laere
Mathieu Vandenbulcke
Louise Emsell
Lower regional gray matter volume in the absence of higher cortical amyloid burden in late-life depression
description Abstract Late-life depression (LLD) is associated with a risk of developing Alzheimer’s disease (AD). However, the role of AD-pathophysiology in LLD, and its association with clinical symptoms and cognitive function are elusive. In this study, one hundred subjects underwent amyloid positron emission tomography (PET) imaging with [18F]-flutemetamol and structural MRI: 48 severely depressed elderly subjects (age 74.1 ± 7.5 years, 33 female) and 52 age-/gender-matched healthy controls (72.4 ± 6.4 years, 37 female). The Geriatric Depression Scale (GDS) and Rey Auditory Verbal Learning Test (RAVLT) were used to assess the severity of depressive symptoms and episodic memory function respectively. Amyloid deposition was quantified using the standardized uptake value ratio. Whole-brain voxel-wise comparisons of amyloid deposition and gray matter volume (GMV) between LLD and controls were performed. Multivariate analysis of covariance was conducted to investigate the association of regional differences in amyloid deposition and GMV with clinical factors, including GDS and RAVLT. As a result, there were no significant group differences in amyloid deposition. In contrast, LLD showed significant lower GMV in the left temporal and parietal region. GMV reduction in the left temporal region was associated with episodic memory dysfunction, but not with depression severity. Regional GMV reduction was not associated with amyloid deposition. LLD is associated with lower GMV in regions that overlap with AD-pathophysiology, and which are associated with episodic memory function. The lack of corresponding associations with amyloid suggests that lower GMV driven by non-amyloid pathology may play a central role in the neurobiology of LLD presenting as a psychiatric disorder. Trial registration: European Union Drug Regulating Authorities Clinical Trials identifier: EudraCT 2009-018064-95.
format article
author Akihiro Takamiya
Thomas Vande Casteele
Michel Koole
François-Laurent De Winter
Filip Bouckaert
Jan Van den Stock
Stefan Sunaert
Patrick Dupont
Rik Vandenberghe
Koen Van Laere
Mathieu Vandenbulcke
Louise Emsell
author_facet Akihiro Takamiya
Thomas Vande Casteele
Michel Koole
François-Laurent De Winter
Filip Bouckaert
Jan Van den Stock
Stefan Sunaert
Patrick Dupont
Rik Vandenberghe
Koen Van Laere
Mathieu Vandenbulcke
Louise Emsell
author_sort Akihiro Takamiya
title Lower regional gray matter volume in the absence of higher cortical amyloid burden in late-life depression
title_short Lower regional gray matter volume in the absence of higher cortical amyloid burden in late-life depression
title_full Lower regional gray matter volume in the absence of higher cortical amyloid burden in late-life depression
title_fullStr Lower regional gray matter volume in the absence of higher cortical amyloid burden in late-life depression
title_full_unstemmed Lower regional gray matter volume in the absence of higher cortical amyloid burden in late-life depression
title_sort lower regional gray matter volume in the absence of higher cortical amyloid burden in late-life depression
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/6cf5814ddb3f4fdf95d048dcf2f41a10
work_keys_str_mv AT akihirotakamiya lowerregionalgraymattervolumeintheabsenceofhighercorticalamyloidburdeninlatelifedepression
AT thomasvandecasteele lowerregionalgraymattervolumeintheabsenceofhighercorticalamyloidburdeninlatelifedepression
AT michelkoole lowerregionalgraymattervolumeintheabsenceofhighercorticalamyloidburdeninlatelifedepression
AT francoislaurentdewinter lowerregionalgraymattervolumeintheabsenceofhighercorticalamyloidburdeninlatelifedepression
AT filipbouckaert lowerregionalgraymattervolumeintheabsenceofhighercorticalamyloidburdeninlatelifedepression
AT janvandenstock lowerregionalgraymattervolumeintheabsenceofhighercorticalamyloidburdeninlatelifedepression
AT stefansunaert lowerregionalgraymattervolumeintheabsenceofhighercorticalamyloidburdeninlatelifedepression
AT patrickdupont lowerregionalgraymattervolumeintheabsenceofhighercorticalamyloidburdeninlatelifedepression
AT rikvandenberghe lowerregionalgraymattervolumeintheabsenceofhighercorticalamyloidburdeninlatelifedepression
AT koenvanlaere lowerregionalgraymattervolumeintheabsenceofhighercorticalamyloidburdeninlatelifedepression
AT mathieuvandenbulcke lowerregionalgraymattervolumeintheabsenceofhighercorticalamyloidburdeninlatelifedepression
AT louiseemsell lowerregionalgraymattervolumeintheabsenceofhighercorticalamyloidburdeninlatelifedepression
_version_ 1718381616545398784